Behandling med InductOs 1, 5 mg/ ml var signifikant mere effektiv i alle frakturklasser, inklusive alvorlige Gustilo IIIB frakturer (52% reduceret risiko for sekundære interventioner sammenlignet med patienter, der modtog standardbehandling).
Treatment with InductOs 1.5 mg/ml was significantly effective in all fracture classes, including severe Gustilo IIIB fractures (52% reduced risk of secondary interventions as compared to standard-care patients).